PCM
CANO

Prelude Capital Management’s Cano Health, Inc. CANO Stock Holding History

Prelude Capital Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-846
Closed -$21.5K – 1485
2023
Q3 		$21.5K Buy
846
+581
+219% +$47.8K ﹤0.01% 1068
2023
Q2 		$36.9K Buy
265
+142
+115% +$18.2K ﹤0.01% 989
2023
Q1 		$11.2K Sell
123
-520
-81% -$70.6K ﹤0.01% 1061
2022
Q4 		$88K Buy
643
+361
+128% +$122K ﹤0.01% 1092
2022
Q3 		$244K Buy
+282
New +$177K 0.01% 981
2021
Q4 		– Sell
-345
Closed -$437K – 2339
2021
Q3 		$437K Buy
+345
New +$418K 0.01% 962
2021
Q2 		– Sell
-200
Closed -$265K – 2064
2021
Q1 		$265K Buy
+200
New +$283K 0.01% 1203

Other funds holding CANO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return